Jeremy Mason, DPM
Podiatrist · Owasso, OKNPI 1710154471
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,779 with a category attached, or 67.5%. Pylant Medical accounts for 78.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,502 and has fallen 97.7% since, to $34 in 2025.
Across 15 payments — averaging $118.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Organogenesis Inc.$142
- Amgen$117
- Dynasplint Systems Inc.$32
- Johnson & Johnson$29
- Averitas Pharma Inc.$20
- plus $39 from 3 others
What the payments were for
- Food & beverage$57933%
- Education$1,20067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 5 | $1,400 |
| Organogenesis Inc. | 2 | $142 |
| Amgen | 1 | $117 |
| Dynasplint Systems Inc. | 1 | $32 |
| Johnson & Johnson | 2 | $29 |
| Averitas Pharma Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,779 in reported general payments places this provider in the 55th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $209 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $159 |
| Methylprednisolone | 13 | $111 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Owasso
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
- James StoughEnid$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.